McDermott Will & Emery’s Of Digital Interest blog provides those in the healthcare and technology industries—from legal professionals and risk managers to app developers—with practical insights into regulatory developments, industry trends and current issues impacting all things digital. We cover a range of topics, including digital health, cross-border data transfers, online tracking, digital advertising, data breaches and global privacy and data protection.
Whether a company’s primary driver of revenue or an essential tool in providing better products and services; technology plays an important role in virtually every business. McDermott’s technology industry practice advises clients on a wide variety of technology-related matters, including acquisition and licensing of technology and IP assets, cloud computing, Software as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS); IT and business process outsourcing (BPO); data hosting, management, privacy and security, distribution agreements, technology development, maintenance, services and licensing, e-commerce and electronic payment systems, mobile apps and social media, open-source software, consulting services and contract manufacturing.
Our renowned lawyers advise clients on all aspects of their business concerns and initiatives, including mergers, acquisitions, joint ventures, technology development, transactions, outsourcing, intellectual property, compliance and operational issues. We also help clients develop the technology infrastructure and strategic relationships required to maximize value and achieve business objectives.
If you have questions or topic suggestions, please let us know via the Contact form, or reach out to one of our editors directly.
- Top Takeaways | Cybersecurity & Insurance Coverage in the Age of Telehealth: Understanding and Mitigating Your Risk
- Telehealth and Prescribing: What’s Permissible in Your State?
- Three Digital Health Trends Affecting Investors in 2021
- Brexit/GDPR: European Commission Publishes Draft Adequacy Decision for Data Transfers
- FDA Issues Artificial Intelligence/Machine Learning Action Plan